Form 8-K - Current report:
SEC Accession No. 0001193125-25-140017
Filing Date
2025-06-12
Accepted
2025-06-12 16:51:22
Documents
12
Period of Report
2025-06-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d98087d8k.htm   iXBRL 8-K 37018
  Complete submission text file 0001193125-25-140017.txt   147853

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA adpt-20250610.xsd EX-101.SCH 2875
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE adpt-20250610_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adpt-20250610_pre.xml EX-101.PRE 10829
15 EXTRACTED XBRL INSTANCE DOCUMENT d98087d8k_htm.xml XML 3549
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38957 | Film No.: 251043596
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)